logo

For the Inventor, By the Inventor

North Caldwell, NJ, United States of America

Andrew D Batcho

This inventor holds 21 USPTO granted patents, primarily in Vitamin D3 Analog Synthesis. Top assignees: Hoffmann-La Roche Inc., Syntex (u.s.a.) Inc., The United States of America as Represented by the Department of. Active years: 1976-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew D Batcho. Retrieved from https://idiyas.com/inventor/andrew-d-batcho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 172(Granted Patents)


Location History:

  • Belleville, NJ (US) (1976)
  • North Caldwell, NJ (US) (1978 - 2002)

Company Filing History:

goldMedal21 out of 5,027 
 
Hoffmann-La Roche Inc.
 patents
silverMedal1 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
bronzeMedal1 out of 28 
 
The United States of America as Represented by the Department of
 patents
where one patent can have more than one assignee

Years Active: 1976-2002

Loading Chart...
Areas of Expertise:
Vitamin D3
Analogs
Synthesis
Metabolites
Trihydroxy-cholecalciferol
Ergocalciferol
Tryptophans
Indoles
Pyrroles
Pyrrolidines
Compounds
Intermediates
21 patents (USPTO):Explore Patents
1. 6452028 - Vitamin D3 analogs (2002-09-17),
2. 6331642 - Vitamin D3 analogs (2001-12-18),
3. 6329538 - Vitamin D3 analogs (2001-12-11),
4. 6040461 - Synthesis of 3-epi vitamin D.sub.3 metabolites and analogs (2000-03-21),
5. 5939408 - Vitamin D.sub.3 analogs (1999-08-17),
6. 5120722 - Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating (1992-06-09),
7. 5110958 - Compounds, process and intermediates (1992-05-05),
8. 4929609 - 25, 28-dihydroxyergocalciferol and 1,25,28-trihydroxyergocalciferol (1990-05-29),
9. 4595776 - Synthesis of 1.alpha.,25-dihydroxyergocalciferol (1986-06-17),
10. 4508651 - Synthesis of 1.alpha.,25-dihydroxyergocalciferol (1985-04-02),
11. 4506078 - 7-Nitroindoles (1985-03-19),
12. 4360470 - Process and intermediates for the synthesis of Vitamin D.sub.3 (1982-11-23),
13. 4316847 - Pyrroles and pyrrolidines (1982-02-23),
14. 4310467 - Process and intermediates for the synthesis of vitamin D.sub.3 (1982-01-12),
15. 4256641 - Novel syntheses of tryptophans (1981-03-17),

Title: Andrew D Batcho: A Pioneer in Vitamin D3 Analogs

Introduction

Andrew D Batcho, based in North Caldwell, NJ, is a prolific inventor with a remarkable portfolio of 21 patents. His contributions to the field of pharmaceutical sciences, particularly in the development of Vitamin D3 analogs, demonstrate his innovative spirit and dedication to advancing healthcare solutions.

Latest Patents

Among his latest patents, Andrew has developed novel Vitamin D3 analogs, focusing on compounds that provide significant therapeutic benefits. These innovations mark crucial steps in addressing various health concerns through improved vitamin D3 formulations.

Career Highlights

Throughout his career, Andrew has worked at notable companies, including Hoffmann-La Roche Inc. and The United States of America as represented by the Department of Defense. His roles in these organizations have allowed him to leverage his expertise in the creation and optimization of pharmaceutical compounds.

Collaborations

Andrew has collaborated with esteemed colleagues, including Milan R Uskokovic and Willy Leimgruber. These partnerships have enriched his work, fostering an environment of shared knowledge and expertise that has propelled advancements in vitamin D research.

Conclusion

With a strong focus on innovation and collaboration, Andrew D Batcho continues to be an influential figure in the realm of pharmaceutical patents, particularly in the development of Vitamin D3 analogs. His ongoing work promises to yield impactful advancements in health and medicine, showcasing the power of inventive thinking.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…